AR123800A1 - Composiciones de relleno para liberación sostenida y cápsulas que las contienen - Google Patents

Composiciones de relleno para liberación sostenida y cápsulas que las contienen

Info

Publication number
AR123800A1
AR123800A1 ARP210102851A ARP210102851A AR123800A1 AR 123800 A1 AR123800 A1 AR 123800A1 AR P210102851 A ARP210102851 A AR P210102851A AR P210102851 A ARP210102851 A AR P210102851A AR 123800 A1 AR123800 A1 AR 123800A1
Authority
AR
Argentina
Prior art keywords
daltons
sustained release
capsule
weight
composition
Prior art date
Application number
ARP210102851A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR123800A1 publication Critical patent/AR123800A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP210102851A 2020-10-16 2021-10-15 Composiciones de relleno para liberación sostenida y cápsulas que las contienen AR123800A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16

Publications (1)

Publication Number Publication Date
AR123800A1 true AR123800A1 (es) 2023-01-11

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102851A AR123800A1 (es) 2020-10-16 2021-10-15 Composiciones de relleno para liberación sostenida y cápsulas que las contienen

Country Status (13)

Country Link
US (1) US20230372252A1 (cg-RX-API-DMAC7.html)
EP (1) EP4228608A4 (cg-RX-API-DMAC7.html)
JP (1) JP7874626B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230088730A (cg-RX-API-DMAC7.html)
CN (1) CN116367864A (cg-RX-API-DMAC7.html)
AR (1) AR123800A1 (cg-RX-API-DMAC7.html)
AU (2) AU2021360905B2 (cg-RX-API-DMAC7.html)
CA (1) CA3195386A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023005368A2 (cg-RX-API-DMAC7.html)
IL (1) IL301692A (cg-RX-API-DMAC7.html)
MX (1) MX2023004441A (cg-RX-API-DMAC7.html)
TW (1) TW202228655A (cg-RX-API-DMAC7.html)
WO (1) WO2022081848A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5406530B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CA2850853A1 (en) * 2011-10-06 2013-04-11 Grunenthal Gmbh Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2978269A1 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
MX2017013634A (es) * 2015-04-24 2018-03-08 Gruenenthal Gmbh Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
WO2020068510A1 (en) * 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Also Published As

Publication number Publication date
IL301692A (en) 2023-05-01
US20230372252A1 (en) 2023-11-23
JP2023545494A (ja) 2023-10-30
JP7874626B2 (ja) 2026-06-16
AU2021360905A9 (en) 2024-10-10
KR20230088730A (ko) 2023-06-20
EP4228608A1 (en) 2023-08-23
NZ799086A (en) 2026-02-27
CO2023005368A2 (es) 2023-05-19
WO2022081848A1 (en) 2022-04-21
CA3195386A1 (en) 2022-04-21
AU2026201700A1 (en) 2026-03-26
AU2021360905A1 (en) 2023-06-01
EP4228608A4 (en) 2024-10-02
MX2023004441A (es) 2023-05-08
AU2021360905B2 (en) 2026-01-08
CN116367864A (zh) 2023-06-30
TW202228655A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
ES2206081T1 (es) Procedimiento para preparar composiciones farmaceuticas para uso con formulaciones de gelatina blanda.
US10105289B2 (en) Biomimetic mineral based endodontic cement composition and uses thereof
ES2804779T3 (es) Cápsulas resistentes a los ácidos
PE20010801A1 (es) Dispositivos para el suministro de farmacos que tienen propiedades antiprogestinicas
HRP20201138T1 (hr) Stabilan farmaceutski sastav za ubrizgavanje antagonista neurokinin 1 receptora i postupak pripreme istoga
BRPI0517674B1 (pt) Sistema de cápsula mole de não-gelatina contendo amido modificado e carragenina com solução de enchimento de natureza básica
CO5570662A2 (es) Formulacion farmaceutica que contiene 3-(3-dimetilamino-1- etil-2-metil-propil) fenol y proporciona una liberacion retardada del ingrediente activo
BR112016028350B1 (pt) método para encapsular material biológico
RU2013151669A (ru) Улучшенная устойчивость пероксида в композициях для ухода за полостью рта
CN1172642A (zh) 多相软明胶药物剂型
AR124044A1 (es) Cápsulas blandas de liberación retardada
AR122316A1 (es) Formulaciones de cápsulas de gel blando de origen no animal, métodos de preparación y métodos de uso de estas
ES2603883T3 (es) Uso de una composición como indicador de oxígeno para formas de administración parenterales y entéricas
CR20170142A (es) Composiciones farmacéuticas resistentes al abuso
AR124043A1 (es) Cápsulas blandas de liberación retardada
CO2023005368A2 (es) Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas
PE20070209A1 (es) Encapsulacion de formulaciones lipidicas en polimeros entericos
CN107375195A (zh) 一种基于壳聚糖的牙周局部药物缓释水凝胶及其应用
AR122512A1 (es) Cápsulas blandas de liberación retardada
ES2785382T3 (es) Liberación sostenida de bimatoprost, análogos de bimatoprost, prostamidas y prostaglandinas para la reducción de grasa
US5908636A (en) Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
Eftekhar et al. Evaluation of hydroxyl ion diffusion in dentin and injectable forms and a simple powder-water calcium hydroxide paste: An in vitro study
MX2021010959A (es) Estabilidad mejorada de ingredientes farmaceuticos activos (api) en capsulas blandas.
ES3021134T3 (en) Dental product for forming an endodontic cement
TW200916108A (en) Stabilized ophthalmic solutions